Kontakt.io, an analytics company focusing on the inpatient healthcare journey, announced it secured $47.5 million in a Series C funding round led by Growth Equity at Goldman Sachs Asset Management (Goldman Sachs).
Christian Resch, partner at Goldman Sachs, will join the company's board of directors.
WHAT IT DOES
Kontakt.io uses AI and real-time Internet of Things (IoT) to garner insights into...
AI-enabled cardiovascular company Cardio Diagnostics Holdings announced it is partnering with care-navigation platform Navierre to make assessing risk and diagnosing heart diseases more accessible.
Cardio Diagnostics Holdings' AI solutions, Epi+GenCHD and PrecisionCHD, use blood samples to provide patients with personalized information regarding their risk for coronary heart disease based on...
Belgium-based brain imaging AI company icometrix announced it received a CPT III code from the American Medical Association enabling reimbursement of its FDA-cleared brain MRI quantification software.
icometrix AI-supported quantitative brain analysis software provides metrics for cerebral MRI scans to help clinicians diagnose, monitor and evaluate treatment responses in patients with...
Canary Speech, maker of speech analysis software, is partnering with Microsoft to apply the tech giant's AI technology to expand its machine learning speech models for healthcare.
Canary offers vocal biomarker technology that captures and analyzes data to determine whether irregularities exist within an individual's speech. The company touts its technology as being able to detect mood, stress and...
CHICAGO — During the Machine Learning and AI for Healthcare Forum at the 2023 HIMSS Global Health Conference & Exhibition here on Monday, panelists discussed the good, the bad and the possibilities for artificial intelligence.
"The opportunity is to really leverage the power of these 0's and 1's in mass, really bring them together and bring out the insights that are actionable at the point...
South Korean medtech firm Coreline Soft has obtained the United States Food and Drug Administration's 510(k) clearance for its latest AI-powered analysis software for screening lung nodules.
The company develops AI imaging solutions for diagnosing various chest conditions, aortic disease, spinal disease, and metastatic cancer in the chest.
WHAT IT DOES
Its latest software-as-a-medical device...
NERVTEX, a Chinese company focused on developing digital therapeutics for brain disorders, has obtained the approval of the China National Medical Products Administration for its AI-powered movement disorder analysis software.
Called MoDAS (Movement Dysfunction Assessment Software), the software as a medical device uses computer vision and deep learning to analyse videos of a patient's movement...
